What Should a Pharmacy Check Before Supplying an Unlicensed Special?

```html

Supplying unlicensed specials in pharmacy practice requires rigorous checks to ensure patient safety, regulatory compliance, and smooth workflow integration. As electronic transmission of prescriptions (e-prescribing) increasingly replaces paper forms, pharmacies can harness digital tools for more accurate demand forecasting, repeat dispensing scheduling, and integrating dispensing workflows. However, supplying unlicensed specials involves unique challenges beyond routine dispensing, especially regarding licensing requirements, clinical need verification, and documentation.

Understanding the Context: What is an Unlicensed Special?

An unlicensed special (or "special") is a medicinal product manufactured or imported to meet the specific needs of a patient when no licensed product is suitable. Unlike licensed medicines, specials have not undergone the full regulatory approval by the MHRA (Medicines and Healthcare products Regulatory Agency), making the responsibility of ensuring quality and safety especially critical.

This regulatory context shapes the pharmacy’s procedural and clinical checking responsibilities before supply. It also underpins the workflow tools needed to support compliance and patient care.

Key Checks Before Supplying an Unlicensed Special

The following checklist summarises the essential verifications a pharmacy must perform before supplying an unlicensed special:

Clinical Need Check – Confirm that a licensed product is not suitable for the patient’s clinical condition.
Licensing and Regulatory Compliance – Ensure the product’s special status is clearly documented and compliant with MHRA guidance.
Prescription Validity and Accuracy – Confirm prescription details are complete, unambiguous, and correctly transmitted.
Supplier Qualification Check – Verify the manufacturer or importer meets GMP and MHRA recognized standards.
Documentation and Record Keeping – Maintain thorough records covering clinical rationale, consent, supplier details, batch numbers, and expiry dates.
Workflow Integration and Traceability – Embed checks within dispensing workflows, utilising barcode scanning and electronic systems for traceability.

1. Clinical Need Check: What Regulatory Requirement is This Step Satisfying?

Regulations mandate pharmacies to establish that an unlicensed special is clinically necessary. According to MHRA and GPhC guidelines, pharmacists must check the prescription to confirm:

No licensed medicine is suitable (e.g. patient allergies, dose form needs).
The prescriber has assessed the clinical need carefully.
The patient understands any risks or uncertainties involved.

This step satisfies the GPhC’s requirement for professional judgement and patient safety, ensuring the unlicensed status is justified clinically, not convenience-based. The clinical need check is not just a box-ticking exercise but requires pharmacist engagement often documented through professional advice notes or patient discussions.

2. Licensing Requirements: What Does the Pharmacy Need to Check?

Pharmacy teams must confirm the product is legally supplied as an unlicensed special under MHRA guidance. Key licensing factors to check include:

Supplier Credentials: The manufacturer or importer must have MHRA recognition and appropriate GMP standards.
Batch Traceability: The batch number, expiry date, and supplier certificates should accompany the product.
Prescriber Authority: The prescriber must be authorised to request an unlicensed special, especially in controlled drug contexts.

These requirements go beyond retail stock checks and resemble aspects of licensing and import control rather than simple logistics — keep a running list of these to avoid confusing regulatory inspection with standard order verification.

3. Electronic Transmission of Prescriptions: Impact on Workflow

The rise of electronic prescription services (EPS) in the UK is rapidly replacing paper scripts, transforming how unlicensed specials are requested and processed.

Accuracy and Speed: EPS reduces transcription errors and lost prescriptions, critical when handling specials where misreading could have serious consequences.
Clear Special Instructions: Pharmacy IT systems connected to EPS can flag unlicensed special requests, triggering dedicated clinical and regulatory checks automatically.
Nomination and Patient Choice: EPS supports patient nomination of preferred pharmacies, helping pharmacies forecast demand for specials and prepare accordingly.

However, not all systems are optimised to handle unlicensed specials. Pharmacies should confirm their dispensing software recognises and prompts special-specific workflows for these prescriptions.

4. Dispensing Workflow Integration: Reducing Errors and Improving Traceability

Integrating unlicensed special checks into dispensing workflows is critical to maintain throughput and safety. Pharmacies increasingly employ robotic dispensing units and barcode traceability systems to manage specials supply.

Barcode Scanning: Scanning batch numbers during picking and final dispense ensures traceability and compliance with MHRA’s expectation of batch-level tracking.
Automated Alerts: Integration with pharmacy workflow software can prompt checking milestones — for example, confirming supplier certificates and expiry dates before release.
Workflow Flags: When a special is identified in the system, the software should force or remind pharmacists to perform the required clinical and regulatory checks.

Each additional scan or workflow step is not just bureaucracy — it impacts throughput costs and staffing. Therefore, it’s vital pharmacies implement only those scans that have a clear regulatory or patient safety justification.

5. Repeat Dispensing Scheduling and Demand Forecasting

For patients needing ongoing supplies of an unlicensed special, repeat dispensing adds complexity:

Pharmacies must liaise closely with prescribers to confirm the continued clinical need at each repeat.
Electronic systems can forecast usage trends, allowing timely reordering from qualified suppliers.
Nomination via EPS enables pharmacies to predict specials demand by patient, helping reduce stockouts or waste.

Forecasting demand for specials is more complicated than for licensed medicines due to variable batch lead times and bespoke formulations. But electronic nomination and repeat dispensing schedules can improve this accuracy significantly.

6. Documentation: Key to Compliance and Quality Assurance

Documentation is paramount for supplying unlicensed specials; it supports audit trails, clinical rationale, and regulatory inspections. Pharmacy teams should ensure records include:

Documentation Type Details to Capture Purpose Clinical Need Justification Notes from pharmacist/prescriber confirming rationale for the special Supports patient safety and professional accountability Prescription Details Complete copy or electronic record of the unlicensed special prescription Verification and audit trail Supplier Certificates Supplier’s MHRA license, GMP certificates, batch certificates of analysis Compliance with licensing requirements Batch and Expiry Records Captured via barcode or manual entry Traceability in case of recalls or adverse events Patient Consent Documented informed consent acknowledging unlicensed status and risks Ethical compliance and risk management

Summary

Supplying an unlicensed special is not the same as dispensing a typical licensed medicine. Pharmacists and their teams must perform a thorough clinical need check, confirm licensing and supplier credentials, manage prescription transmission accuracy, and document every step accurately. Electronic transmission of prescriptions offers opportunities to reduce errors and integrate unlicensed specials seamlessly into dispensing workflows, but pharmacy systems must be configured specifically to handle these products.

Managing repeat dispensing and nomination through EPS further assists patient-centred care by forecasting demand and scheduling supplies efficiently. Barcode scanning and robotic dispensing augment traceability and regulatory compliance but must be implemented with an eye on throughput costs and businesscomputingworld.co.uk real regulatory requirements rather than simply adding "digital transformation" steps.

Focusing on these checks ensures pharmacies meet both the letter and spirit of MHRA and GPhC guidance, maintaining patient safety and professional best practice when supplying specials.

```